Neglected Tropical Diseases Drugs and Vaccines Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Neglected Tropical Diseases Drugs and Vaccines Market to 2027 - Global Analysis and Forecasts By Disease (Malaria, Ebola, Dengue, Chagas, Leishmaniasis, Zika Virus); Product (Drugs, Vaccines)

Report Code: TIPRE00005216 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Neglected Tropical Diseases consists of diseases that affect the developing countries in a large scale, but because of increasing international migration, these diseases are now a concern of the developed countries too.

MARKET DYNAMICS
The Neglected Tropical Diseases Drugs and Vaccines market is anticipated to grow in the forecast, owing to the factors such as increasing issues like sanitation, cleanliness and hygiene, growing migrant population in developed countries, increasing public-private partnership and need for quality drugs.

MARKET SCOPE
The "Global Neglected Tropical Diseases Drugs and Vaccines Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of Neglected Tropical Diseases Drugs and Vaccines market with detailed market segmentation by Disease, Product and geography. The global Neglected Tropical Diseases Drugs and Vaccines market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Neglected Tropical Diseases Drugs and Vaccines market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Neglected Tropical Diseases Drugs and Vaccines market is segmented on the basis of Disease and Product. Based on Disease the market is segmented into Malaria, Ebola, Dengue, Chagas, Leishmaniasis, Zika Virus. Based on Product the market is segmented into Drugs, Vaccines.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Neglected Tropical Diseases Drugs and Vaccines market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Neglected Tropical Diseases Drugs and Vaccines market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Neglected Tropical Diseases Drugs And Vaccines market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Neglected Tropical Diseases Drugs and Vaccines market in these regions.

MARKET PLAYERS
The reports cover key developments in the Neglected Tropical Diseases Drugs and Vaccines market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Neglected Tropical Diseases Drugs and Vaccines market are anticipated to lucrative growth opportunities in the future with the rising demand for Neglected Tropical Diseases Drugs and Vaccines market in the global market. Below mentioned is the list of few companies engaged in the Neglected Tropical Diseases Drugs and Vaccines market.
The report also includes the profiles of Neglected Tropical Diseases Drugs and Vaccines market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc
  • Sanofi Pasteur
  • Eisai Co., Ltd
  • SABIN VACCINE INSTITUTE
  • Merck KGaA
  • Astellas Pharma Inc
  • Takeda Pharmaceutical Company Limited
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Neglected Tropical Diseases Drugs And Vaccines Market - By Disease
1.3.2 Neglected Tropical Diseases Drugs And Vaccines Market - By Product
1.3.3 Neglected Tropical Diseases Drugs And Vaccines Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NEGLECTED TROPICAL DISEASES DRUGS AND VACCINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NEGLECTED TROPICAL DISEASES DRUGS AND VACCINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NEGLECTED TROPICAL DISEASES DRUGS AND VACCINES MARKET - GLOBAL MARKET ANALYSIS
6.1. NEGLECTED TROPICAL DISEASES DRUGS AND VACCINES - GLOBAL MARKET OVERVIEW
6.2. NEGLECTED TROPICAL DISEASES DRUGS AND VACCINES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. NEGLECTED TROPICAL DISEASES DRUGS AND VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE
7.1. OVERVIEW
7.2. DISEASE MARKET FORECASTS AND ANALYSIS
7.3. MALARIA
7.3.1. Overview
7.3.2. Malaria Market Forecast and Analysis
7.4. EBOLA
7.4.1. Overview
7.4.2. Ebola Market Forecast and Analysis
7.5. DENGUE
7.5.1. Overview
7.5.2. Dengue Market Forecast and Analysis
7.6. CHAGAS
7.6.1. Overview
7.6.2. Chagas Market Forecast and Analysis
7.7. LEISHMANIASIS
7.7.1. Overview
7.7.2. Leishmaniasis Market Forecast and Analysis
7.8. ZIKA VIRUS
7.8.1. Overview
7.8.2. Zika Virus Market Forecast and Analysis
8. NEGLECTED TROPICAL DISEASES DRUGS AND VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
8.1. OVERVIEW
8.2. PRODUCT MARKET FORECASTS AND ANALYSIS
8.3. DRUGS
8.3.1. Overview
8.3.2. Drugs Market Forecast and Analysis
8.4. VACCINES
8.4.1. Overview
8.4.2. Vaccines Market Forecast and Analysis
9. NEGLECTED TROPICAL DISEASES DRUGS AND VACCINES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Neglected Tropical Diseases Drugs And Vaccines Market Overview
9.1.2 North America Neglected Tropical Diseases Drugs And Vaccines Market Forecasts and Analysis
9.1.3 North America Neglected Tropical Diseases Drugs And Vaccines Market Forecasts and Analysis - By Disease
9.1.4 North America Neglected Tropical Diseases Drugs And Vaccines Market Forecasts and Analysis - By Product
9.1.5 North America Neglected Tropical Diseases Drugs And Vaccines Market Forecasts and Analysis - By Countries
9.1.5.1 United States Neglected Tropical Diseases Drugs And Vaccines Market
9.1.5.1.1 United States Neglected Tropical Diseases Drugs And Vaccines Market by Disease
9.1.5.1.2 United States Neglected Tropical Diseases Drugs And Vaccines Market by Product
9.1.5.2 Canada Neglected Tropical Diseases Drugs And Vaccines Market
9.1.5.2.1 Canada Neglected Tropical Diseases Drugs And Vaccines Market by Disease
9.1.5.2.2 Canada Neglected Tropical Diseases Drugs And Vaccines Market by Product
9.1.5.3 Mexico Neglected Tropical Diseases Drugs And Vaccines Market
9.1.5.3.1 Mexico Neglected Tropical Diseases Drugs And Vaccines Market by Disease
9.1.5.3.2 Mexico Neglected Tropical Diseases Drugs And Vaccines Market by Product
9.2. EUROPE
9.2.1 Europe Neglected Tropical Diseases Drugs And Vaccines Market Overview
9.2.2 Europe Neglected Tropical Diseases Drugs And Vaccines Market Forecasts and Analysis
9.2.3 Europe Neglected Tropical Diseases Drugs And Vaccines Market Forecasts and Analysis - By Disease
9.2.4 Europe Neglected Tropical Diseases Drugs And Vaccines Market Forecasts and Analysis - By Product
9.2.5 Europe Neglected Tropical Diseases Drugs And Vaccines Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Neglected Tropical Diseases Drugs And Vaccines Market
9.2.5.1.1 Germany Neglected Tropical Diseases Drugs And Vaccines Market by Disease
9.2.5.1.2 Germany Neglected Tropical Diseases Drugs And Vaccines Market by Product
9.2.5.2 France Neglected Tropical Diseases Drugs And Vaccines Market
9.2.5.2.1 France Neglected Tropical Diseases Drugs And Vaccines Market by Disease
9.2.5.2.2 France Neglected Tropical Diseases Drugs And Vaccines Market by Product
9.2.5.3 Italy Neglected Tropical Diseases Drugs And Vaccines Market
9.2.5.3.1 Italy Neglected Tropical Diseases Drugs And Vaccines Market by Disease
9.2.5.3.2 Italy Neglected Tropical Diseases Drugs And Vaccines Market by Product
9.2.5.4 Spain Neglected Tropical Diseases Drugs And Vaccines Market
9.2.5.4.1 Spain Neglected Tropical Diseases Drugs And Vaccines Market by Disease
9.2.5.4.2 Spain Neglected Tropical Diseases Drugs And Vaccines Market by Product
9.2.5.5 United Kingdom Neglected Tropical Diseases Drugs And Vaccines Market
9.2.5.5.1 United Kingdom Neglected Tropical Diseases Drugs And Vaccines Market by Disease
9.2.5.5.2 United Kingdom Neglected Tropical Diseases Drugs And Vaccines Market by Product
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Neglected Tropical Diseases Drugs And Vaccines Market Overview
9.3.2 Asia-Pacific Neglected Tropical Diseases Drugs And Vaccines Market Forecasts and Analysis
9.3.3 Asia-Pacific Neglected Tropical Diseases Drugs And Vaccines Market Forecasts and Analysis - By Disease
9.3.4 Asia-Pacific Neglected Tropical Diseases Drugs And Vaccines Market Forecasts and Analysis - By Product
9.3.5 Asia-Pacific Neglected Tropical Diseases Drugs And Vaccines Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Neglected Tropical Diseases Drugs And Vaccines Market
9.3.5.1.1 Australia Neglected Tropical Diseases Drugs And Vaccines Market by Disease
9.3.5.1.2 Australia Neglected Tropical Diseases Drugs And Vaccines Market by Product
9.3.5.2 China Neglected Tropical Diseases Drugs And Vaccines Market
9.3.5.2.1 China Neglected Tropical Diseases Drugs And Vaccines Market by Disease
9.3.5.2.2 China Neglected Tropical Diseases Drugs And Vaccines Market by Product
9.3.5.3 India Neglected Tropical Diseases Drugs And Vaccines Market
9.3.5.3.1 India Neglected Tropical Diseases Drugs And Vaccines Market by Disease
9.3.5.3.2 India Neglected Tropical Diseases Drugs And Vaccines Market by Product
9.3.5.4 Japan Neglected Tropical Diseases Drugs And Vaccines Market
9.3.5.4.1 Japan Neglected Tropical Diseases Drugs And Vaccines Market by Disease
9.3.5.4.2 Japan Neglected Tropical Diseases Drugs And Vaccines Market by Product
9.3.5.5 South Korea Neglected Tropical Diseases Drugs And Vaccines Market
9.3.5.5.1 South Korea Neglected Tropical Diseases Drugs And Vaccines Market by Disease
9.3.5.5.2 South Korea Neglected Tropical Diseases Drugs And Vaccines Market by Product
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Neglected Tropical Diseases Drugs And Vaccines Market Overview
9.4.2 Middle East and Africa Neglected Tropical Diseases Drugs And Vaccines Market Forecasts and Analysis
9.4.3 Middle East and Africa Neglected Tropical Diseases Drugs And Vaccines Market Forecasts and Analysis - By Disease
9.4.4 Middle East and Africa Neglected Tropical Diseases Drugs And Vaccines Market Forecasts and Analysis - By Product
9.4.5 Middle East and Africa Neglected Tropical Diseases Drugs And Vaccines Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Neglected Tropical Diseases Drugs And Vaccines Market
9.4.5.1.1 South Africa Neglected Tropical Diseases Drugs And Vaccines Market by Disease
9.4.5.1.2 South Africa Neglected Tropical Diseases Drugs And Vaccines Market by Product
9.4.5.2 Saudi Arabia Neglected Tropical Diseases Drugs And Vaccines Market
9.4.5.2.1 Saudi Arabia Neglected Tropical Diseases Drugs And Vaccines Market by Disease
9.4.5.2.2 Saudi Arabia Neglected Tropical Diseases Drugs And Vaccines Market by Product
9.4.5.3 U.A.E Neglected Tropical Diseases Drugs And Vaccines Market
9.4.5.3.1 U.A.E Neglected Tropical Diseases Drugs And Vaccines Market by Disease
9.4.5.3.2 U.A.E Neglected Tropical Diseases Drugs And Vaccines Market by Product
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Neglected Tropical Diseases Drugs And Vaccines Market Overview
9.5.2 South and Central America Neglected Tropical Diseases Drugs And Vaccines Market Forecasts and Analysis
9.5.3 South and Central America Neglected Tropical Diseases Drugs And Vaccines Market Forecasts and Analysis - By Disease
9.5.4 South and Central America Neglected Tropical Diseases Drugs And Vaccines Market Forecasts and Analysis - By Product
9.5.5 South and Central America Neglected Tropical Diseases Drugs And Vaccines Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Neglected Tropical Diseases Drugs And Vaccines Market
9.5.5.1.1 Brazil Neglected Tropical Diseases Drugs And Vaccines Market by Disease
9.5.5.1.2 Brazil Neglected Tropical Diseases Drugs And Vaccines Market by Product
9.5.5.2 Argentina Neglected Tropical Diseases Drugs And Vaccines Market
9.5.5.2.1 Argentina Neglected Tropical Diseases Drugs And Vaccines Market by Disease
9.5.5.2.2 Argentina Neglected Tropical Diseases Drugs And Vaccines Market by Product
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. NEGLECTED TROPICAL DISEASES DRUGS AND VACCINES MARKET, KEY COMPANY PROFILES
11.1. GLAXOSMITHKLINE PLC
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. NOVARTIS AG
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. PFIZER INC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. SANOFI PASTEUR
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. EISAI CO., LTD
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. SABIN VACCINE INSTITUTE
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MERCK KGAA
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. ASTELLAS PHARMA INC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. TAKEDA PHARMACEUTICAL COMPANY LIMITED
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

- GlaxoSmithKline plc
- Novartis AG
- Pfizer Inc
- Sanofi Pasteur
- Eisai Co., Ltd
- SABIN VACCINE INSTITUTE
- Merck KGaA
- Astellas Pharma Inc
- Takeda Pharmaceutical Company Limited